Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Apatinib|RADIATION: SBRT
Sponsor: Yan Li
Collaborators: Jiangsu HengRui Medicine Co., Ltd.